Indag Rubber Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 15, 2025, 5:48 pm

Competitors of Indag Rubber Ltd

All Competitor Stocks of Indag Rubber Ltd

Quarterly Result

Last Updated: August 19, 2025, 1:25 pm

Below is a detailed analysis of the quarterly data for Indag Rubber Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 45.01 Cr.. The value appears to be declining and may need further review. It has decreased from 55.07 Cr. (Mar 2025) to 45.01 Cr., marking a decrease of 10.06 Cr..
• For Expenses, as of Jun 2025, the value is 44.75 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 55.36 Cr. (Mar 2025) to 44.75 Cr., marking a decrease of 10.61 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.26 Cr.. The value appears strong and on an upward trend. It has increased from -0.29 Cr. (Mar 2025) to 0.26 Cr., marking an increase of 0.55 Cr..
• For OPM %, as of Jun 2025, the value is 0.58%. The value appears strong and on an upward trend. It has increased from -0.53% (Mar 2025) to 0.58%, marking an increase of 1.11%.
• For Other Income, as of Jun 2025, the value is 2.88 Cr.. The value appears strong and on an upward trend. It has increased from 2.71 Cr. (Mar 2025) to 2.88 Cr., marking an increase of 0.17 Cr..
• For Interest, as of Jun 2025, the value is 0.23 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.23 Cr..
• For Depreciation, as of Jun 2025, the value is 1.71 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.66 Cr. (Mar 2025) to 1.71 Cr., marking an increase of 0.05 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.20 Cr.. The value appears strong and on an upward trend. It has increased from 0.53 Cr. (Mar 2025) to 1.20 Cr., marking an increase of 0.67 Cr..
• For Tax %, as of Jun 2025, the value is 29.17%. The value appears to be increasing, which may not be favorable. It has increased from 1.89% (Mar 2025) to 29.17%, marking an increase of 27.28%.
• For Net Profit, as of Jun 2025, the value is 0.85 Cr.. The value appears strong and on an upward trend. It has increased from 0.51 Cr. (Mar 2025) to 0.85 Cr., marking an increase of 0.34 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.51. The value appears strong and on an upward trend. It has increased from 0.41 (Mar 2025) to 0.51, marking an increase of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:06 am

Growth

Last Updated: September 5, 2025, 3:46 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Indag Rubber Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 6.15 (Mar 24) to 2.49, marking a decrease of 3.66.
• For Diluted EPS (Rs.), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 5. It has decreased from 6.15 (Mar 24) to 2.49, marking a decrease of 3.66.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.32. This value is within the healthy range. It has decreased from 7.96 (Mar 24) to 4.32, marking a decrease of 3.64.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 86.70. It has decreased from 87.46 (Mar 24) to 86.70, marking a decrease of 0.76.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 86.70. It has decreased from 87.46 (Mar 24) to 86.70, marking a decrease of 0.76.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 87.02. It has decreased from 95.69 (Mar 24) to 87.02, marking a decrease of 8.67.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 5.17. This value is within the healthy range. It has decreased from 10.08 (Mar 24) to 5.17, marking a decrease of 4.91.
• For PBIT / Share (Rs.), as of Mar 25, the value is 2.65. This value is within the healthy range. It has decreased from 8.06 (Mar 24) to 2.65, marking a decrease of 5.41.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.27. This value is within the healthy range. It has decreased from 7.79 (Mar 24) to 2.27, marking a decrease of 5.52.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 2. It has decreased from 5.94 (Mar 24) to 1.80, marking a decrease of 4.14.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.49. This value is within the healthy range. It has decreased from 6.15 (Mar 24) to 2.49, marking a decrease of 3.66.
• For PBDIT Margin (%), as of Mar 25, the value is 5.93. This value is below the healthy minimum of 10. It has decreased from 10.53 (Mar 24) to 5.93, marking a decrease of 4.60.
• For PBIT Margin (%), as of Mar 25, the value is 3.03. This value is below the healthy minimum of 10. It has decreased from 8.42 (Mar 24) to 3.03, marking a decrease of 5.39.
• For PBT Margin (%), as of Mar 25, the value is 2.60. This value is below the healthy minimum of 10. It has decreased from 8.14 (Mar 24) to 2.60, marking a decrease of 5.54.
• For Net Profit Margin (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 5. It has decreased from 6.20 (Mar 24) to 2.06, marking a decrease of 4.14.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.85. This value is below the healthy minimum of 8. It has decreased from 6.43 (Mar 24) to 2.85, marking a decrease of 3.58.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.86. This value is below the healthy minimum of 15. It has decreased from 7.14 (Mar 24) to 2.86, marking a decrease of 4.28.
• For Return on Capital Employeed (%), as of Mar 25, the value is 2.83. This value is below the healthy minimum of 10. It has decreased from 8.69 (Mar 24) to 2.83, marking a decrease of 5.86.
• For Return On Assets (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 5. It has decreased from 5.94 (Mar 24) to 2.37, marking a decrease of 3.57.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has increased from 0.00 (Mar 24) to 0.83, marking an increase of 0.83.
• For Current Ratio (X), as of Mar 25, the value is 3.82. This value exceeds the healthy maximum of 3. It has increased from 3.52 (Mar 24) to 3.82, marking an increase of 0.30.
• For Quick Ratio (X), as of Mar 25, the value is 2.30. This value exceeds the healthy maximum of 2. It has increased from 2.09 (Mar 24) to 2.30, marking an increase of 0.21.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.28. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 5.28, marking an increase of 5.28.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 120.56. This value exceeds the healthy maximum of 50. It has increased from 38.99 (Mar 24) to 120.56, marking an increase of 81.57.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 59.88. This value exceeds the healthy maximum of 50. It has increased from 29.36 (Mar 24) to 59.88, marking an increase of 30.52.
• For Earning Retention Ratio (%), as of Mar 25, the value is -20.56. This value is below the healthy minimum of 40. It has decreased from 61.01 (Mar 24) to -20.56, marking a decrease of 81.57.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 40.12. This value is within the healthy range. It has decreased from 70.64 (Mar 24) to 40.12, marking a decrease of 30.52.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 13.74. This value is within the healthy range. It has decreased from 37.44 (Mar 24) to 13.74, marking a decrease of 23.70.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.78. This value is within the healthy range. It has decreased from 23.06 (Mar 24) to 5.78, marking a decrease of 17.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 315.77. It has decreased from 352.97 (Mar 24) to 315.77, marking a decrease of 37.20.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.41 (Mar 24) to 1.38, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 23.28. This value exceeds the healthy maximum of 15. It has increased from 13.34 (Mar 24) to 23.28, marking an increase of 9.94.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.38, marking a decrease of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is -20.56. This value is below the healthy minimum of 30. It has decreased from 61.00 (Mar 24) to -20.56, marking a decrease of 81.56.
• For Price / BV (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.57 (Mar 24) to 1.38, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.38. This value is within the healthy range. It has decreased from 1.42 (Mar 24) to 1.38, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness